Drugs / cfMSCs
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07495956 | Mar 2026 → Mar 2029 expected | type 2 diabetes mellitus | Shenzhen Geno-Immune Medical Institute | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cfMSCs | “Clonal fetal mesenchymal stem cells (cfMSCs) therapy for type II diabetes mellitus” NCT07495956 ↗ |
| Route | Intravenous | “intravenous infusion of cfMSCs” NCT07495956 ↗ |